Does Zenas BioPharma (ZBIO) Shifting Into Russell Growth Indices Recast Its Core Investment Story?
In June 2026, Zenas BioPharma, Inc. (NasdaqGS: ZBIO) was added to several Russell growth benchmarks, including the Russell 2000 Growth, 2500 Growth, 3000 Growth, 3000E Growth and Small Cap Comp Growth indices, while being removed from multiple value-oriented Russell indices as part of the latest rebalancing. This shift from value to growth classifications across the Russell family highlights how the market’s style indices are reassessing Zenas BioPharma’s profile within small- and micro-cap...
What's Your Reaction?











